ATW SPAC Management’s Estrella Immunopharma ESLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.4K | Hold |
40,000
| – | – | 0.06% | 63 |
|
|
2025
Q1 | $37.1K | Hold |
40,000
| – | – | 0.06% | 55 |
|
|
2024
Q4 | $48K | Hold |
40,000
| – | – | 0.07% | 50 |
|
|
2024
Q3 | $46.4K | Hold |
40,000
| – | – | 0.05% | 67 |
|
|
2024
Q2 | $42K | Hold |
40,000
| – | – | 0.05% | 66 |
|
|
2024
Q1 | $49.6K | Hold |
40,000
| – | – | 0.06% | 57 |
|
|
2023
Q4 | $44.4K | Buy |
+40,000
| New | +$44.4K | 0.06% | 61 |
|
|
2022
Q4 | – | Sell |
-390,000
| Closed | -$3.93M | – | 209 |
|
|
2022
Q3 | $3.93M | Hold |
390,000
| – | – | 0.63% | 69 |
|
|
2022
Q2 | $3.9M | Hold |
390,000
| – | – | 0.56% | 72 |
|
|
2022
Q1 | $3.9K | Hold |
390,000
| – | – | 0.53% | 72 |
|
|
2021
Q4 | $3.87M | Hold |
390,000
| – | – | 0.59% | 64 |
|
|
2021
Q3 | $3.86M | Buy |
+390,000
| New | +$3.86M | 0.72% | 51 |
|